| 000 | 01774 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515045631.0 | ||
| 264 | 0 | _c20070403 | |
| 008 | 200704s 0 0 eng d | ||
| 022 | _a0960-894X | ||
| 024 | 7 |
_a10.1016/j.bmcl.2006.10.052 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeyers, Kenneth M | |
| 245 | 0 | 0 |
_aAminomethyl tetrahydronaphthalene ketopiperazine MCH-R1 antagonists--Increasing selectivity over hERG. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _cFeb 2007 |
||
| 300 |
_a819-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aERG1 Potassium Channel |
| 650 | 0 | 4 |
_aEther-A-Go-Go Potassium Channels _xdrug effects |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIndicators and Reagents |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNaphthalenes _xchemical synthesis |
| 650 | 0 | 4 |
_aPiperazines _xchemical synthesis |
| 650 | 0 | 4 |
_aPotassium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Somatostatin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aWeight Loss _xdrug effects |
| 700 | 1 | _aMéndez-Andino, José L | |
| 700 | 1 | _aColson, Anny-Odile | |
| 700 | 1 | _aWarshakoon, Namal C | |
| 700 | 1 | _aWos, John A | |
| 700 | 1 | _aMitchell, Maria C | |
| 700 | 1 | _aHodge, Karen M | |
| 700 | 1 | _aHoward, Jeremy M | |
| 700 | 1 | _aAckley, David C | |
| 700 | 1 | _aHolbert, Jerry K | |
| 700 | 1 | _aMittelstadt, Scott W | |
| 700 | 1 | _aDowty, Martin E | |
| 700 | 1 | _aObringer, Cindy M | |
| 700 | 1 | _aReizes, Ofer | |
| 700 | 1 | _aHu, X Eric | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 17 _gno. 3 _gp. 819-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2006.10.052 _zAvailable from publisher's website |
| 999 |
_c16679861 _d16679861 |
||